glp-1 myths GLP-1: Miracle, Myth, or Metabolic Reset? A Functional Medicine Deep Dive Beyond the Hype 6 weight loss medication myths
Description
Semaglutide: the weekly standard Semaglutide remains the most widely prescribed GLP-1 receptor agonist for weight management
As a result, the launch has arrived later than originally expected

2023;388:e22
Teraptik rnler daresi (TGA), 2 Aralk 2020

Tirzepatide came off the FDA shortage list in December 2024 (enforcement discretion ended March 2025)

Journal of Sexual Medicine / PMC Clinical review: how GLP-1 obesity medications may decrease sexual desire PMC (NIH) Anorgasmia following initiation of a GLP-1 agonist PLOS One / PMC Weight loss, testosterone, SHBG, and erectile function in overweight and obese men Andrologia (meta-analysis) Effect of weight loss on erectile function in men with overweight or obesity PubMed Sexual Function, Obesity, and Weight Loss in Men and Women PMC (NIH) / Healthcare Hormonal profile, weight, and sexual function in women with PCOS Indiana University, Kinsey Institute Survey on GLP-1s, sex, and dating
